Downregulation of the Ornithine Decarboxylase/polyamine System Inhibits Angiotensin-induced Hypertrophy of Cardiomyocytes Through the NO/cGMP-dependent Protein Kinase Type-I Pathway

Background: Polyamines and nitric oxide (NO) have been involved in the pathogenesis of cardiac hypertrophy. NO can regulate cardiac ion channels by direct actions on G-proteins and adenyl cyclase. The present study was undertaken to elucidate the molecular mechanism of interactions with polyamines and NO in cardiac hypertrophy. Methods: Cardiaomyocyte hypertrophy was induced by angiotensinII (AngII). Hypertrophy was estimated by cell-surface area, atrial natriuretic peptide (ANP) mRNA expression, and the immunofluorescence of phalloidin. Pretreatment with alpha-difluoromethylornithine (DFMO) was done to deplete putrescine; KT5823 pretreatment was carried out to block the nitric oxide/cGMP-dependent protein kinase type-I (NO/PKG-I) pathway. Expressions of endothelial nitric oxide synthase (eNOS), PKG-I, c-fos and c-myc were analyzed by western blotting and immunofluorescence. The intracellular concentration of free calcium ([Ca2+]i) was determined by confocal laser scanning microscopy. Results: Hypertrophy of cardiomyocytes was induced by AngII, this caused an increase in putrescine, spermidine and total polyamine pool in association with a decreased level of NO. Expressions of eNOS and PKG-I were down-regulated, [Ca2+]i was increased, and expressions of c-Fos and c-Myc upregulated. DFMO reversed these changes induced by AngII. Conclusions: Downregulation of polyamines inhibits cardiomyocyte hypertrophy, which is closely related to [Ca2+]i and the NO/PKG-I pathway.

[1]  L. Ignarro,et al.  Potential cardioprotective actions of no-releasing aspirin , 2002, Nature Reviews Drug Discovery.

[2]  L. Shantz,et al.  Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy. , 2001, The Biochemical journal.

[3]  H. Drexler,et al.  Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. , 2003, Cardiovascular research.

[4]  T. Patel,et al.  Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. , 1999, The American journal of physiology.

[5]  L. Shantz,et al.  Targeted overexpression of ornithine decarboxylase enhances β-adrenergic agonist-induced cardiac hypertrophy , 2001 .

[6]  N. Parameswaran,et al.  Adrenomedullin Increases AP-1 Expression in Rat Mesangial Cells via Activation of Protein Kinase-A and p38 MAPK , 2003, Cellular Physiology and Biochemistry.

[7]  J. Molkentin,et al.  Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. , 2002, Circulation research.

[8]  D. Welch,et al.  Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells , 2004, Clinical & Experimental Metastasis.

[9]  Guangping Chen,et al.  All-trans retinoic acid induction of sulfotransferases. , 2005, Basic & clinical pharmacology & toxicology.

[10]  Y. Yazaki,et al.  Control of cardiac gene expression by mechanical stress. , 1993, Annual review of physiology.

[11]  Hongzhu Li,et al.  L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways. , 2008, Basic & clinical pharmacology & toxicology.

[12]  Qin M. Chen,et al.  Molecular mechanisms of cardiac hypertrophy induced by toxicants , 2007, Cardiovascular Toxicology.

[13]  F. Hofmann,et al.  cGMP-Dependent Protein Kinase I Mediates the Negative Inotropic Effect of cGMP in the Murine Myocardium , 2002, Circulation research.

[14]  G. Dorn,et al.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy. , 2001, Annual review of physiology.

[15]  L. Ignarro,et al.  Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Hughes,et al.  Role of polyamines in hypertension induced by angiotensin II. , 1995, Cardiovascular research.

[17]  Rui Wang,et al.  Expression of voltage-dependent K+ channel genes in mesenteric artery smooth muscle cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[18]  J. Frost,et al.  Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy , 1994, The Journal of cell biology.

[19]  J. Sadoshima,et al.  The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.

[20]  Yen-Ling Chen,et al.  Nitric Oxide Inhibits Endothelin-1-Induced Cardiomyocyte Hypertrophy through cGMP-mediated Suppression of Extracellular-Signal Regulated Kinase Phosphorylation , 2005, Molecular Pharmacology.

[21]  D. Mann,et al.  Mechanisms and models in heart failure: A combinatorial approach. , 1999, Circulation.

[22]  K. Chien,et al.  Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.

[23]  A. Pegg,et al.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.

[24]  H. Guo,et al.  Multiple polyamine regulatory pathways control compensatory cardiovascular hypertrophy in coarctation hypertension. , 1997, Clinical and experimental hypertension.

[25]  H. Drexler,et al.  Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Sadoshima,et al.  Critical Role of the AT1 Receptor Subtype , 2005 .

[27]  T. Menges,et al.  Nitric oxide and polyamine pathway-dependent modulation of neutrophil free amino- and α-keto acid profiles or host defense capability , 2006, Amino Acids.

[28]  J. Bronzwaer,et al.  Nitric oxide's role in the heart: control of beating or breathing? , 2004, American journal of physiology. Heart and circulatory physiology.

[29]  M. Salvi,et al.  Effects of polyamines on mitochondrial Ca(2+) transport. , 2004, Biochimica et biophysica acta.

[30]  E. Olson,et al.  Decoding calcium signals involved in cardiac growth and function , 2000, Nature Medicine.